New Market Research Report: CryoLife, Inc. (CRY) - Product Pipeline Analysis, 2013 Update

Boston, MA -- (SBWIRE) -- 07/26/2013 -- CryoLife, Inc. (CryoLife) is a biological medical device company that develops and commercializes biomaterials, implantable medical devices and surgical adhesives, and also preserves and distributes human tissues for cardiovascular and vascular transplant applications. The company's product portfolio includes CryoValve SG pulmonary heart valve, CryoPatch SG pulmonary cardiac patch tissue and surgical sealants and hemostats including BioGlue surgical adhesive, BioFoam surgical Matrix, and PerClot absorbable powdered hemostat. The company through its subsidiary Cardiogenesis Corporation specializes in the treatment of coronary artery disease using a laser console system and single use, fiber-optic handpieces to treat patients with severe angina. Additionally, CryoLife and its subsidiary, Hemosphere, Inc. markets the Hemodialysis Reliable Outflow Graft (HeRO Graft). The company distributes its preserved human cardiac and vascular tissues to implanting institutions across the US, Canada, and Europe. CryoLife is headquartered in Georgia, the US.